Aniticancer mechanisms of repurposed drugs in oncology on hamster model
Popović, Kosta J.
Popović, Jovan K.
Lalošević, Dušan
Čapo, Ivan
Dolićanin, Zana
Popović, Dušica J.
Miljković, Dejan
Abstract: Transcription factor NF-kB acts as an important target in oncology, as most of the molecules formed by transcription of genes trigger cancers. Also, ROS (Reactive Oxygen Species) activity is interconnected with NF-kB and cancer development. To identify NF-kB inhibition and/or ROS stimulation as antitumor mechanisms, we have screened combinations of currently approved non-oncological repurposed drugs that can inhibit hamster fibrosarcoma growth by rescuing cancer development with NF-kB stimulation and/or ROS inhibition.
engleski
2023
© All rights reserved
Keywords : fibrosarcoma, hamsters, repurposed drugs, NF-kB, ROS.